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Abstract 
Thymosin beta 4 (Tβ4) and thymosin beta
10 (Tβ10) are two members of the β-thymosin
family, involved in multiple cellular activities
in different organs in multiple animal species.
Here we report the expression pattern of Tβ4
and Tβ10 in rat tissues, in the gut and in
annexed glands. The two peptide were differ-
ently expressed: Tβ4 was absent in salivary
glands whereas Tβ10 was expressed in parotid
and in submandibular glands. Tβ4 was mildly
expressed in the tongue and in the oesopha-
gus, where Tβ10 was absent. A similar expres-
sion was found in the stomach, ileum and
colon mucosa. In pancreas Tβ4 reactivity was
restricted to the Langerhans islet cells; Tβ4
was also detected in the exocrine cells. Both
peptide were not expressed in liver cells. When
the rat expression pattern in rat organs was
compared to reactivity for Tβ4 and Tβ10 in
humans, marked differences were found. Our
data clearly indicate a species-specific expres-
sion of Tβ4 and Tβ10, characterized by the
actual unpredictability of the expression of
these peptides in different cells and tissues.
The common high expression of Tβ4 in mast
cells, both in humans and in rats, represents
one of the few similarities between these two
species.
Introduction
Beta thymosins are a versatile family of
small peptides expressed in multiple tissues in
mammals, that show many intracellular and
extracellular activities.1,2 These peptides are
named thymosins after their first isolation in
the calf thymus.3 Fifteen highly homologous
beta thymosin variants, containing 40 to 44
amino acid residues, have been described.4
Among beta thymosins, thymosin beta 4
(Tβ4)5,6 and thymosin beta 10 (Tβ10)7 are the
most abundant in human cells and rat tissues.8
During the years, beta thymosins have been
detected inside of cells of different organs,9-14
as well as in human blood,15 in human saliva,16
in tears17 and in wound fluid after abdominal
surgery.18 Many physiological properties and
cellular functions are connected to Tβ4: G-
actin-sequestering,1 promotion of cell migra-
tion,8 angiogenesis,9,19 stem cell differentia-
tion,11 modulation of cytokines and
chemokines.20 This peptide is also involved in
lesion-induced neuroplasticity through
microglia upregulation and it participates in
the growth of neuronal processes.21 Therefore,
the mRNA encoding for Tβ4 is expressed in
mouse embryonic stem cells and in mesoder-
mal-like cells (cardiac and skeletal muscle).22
Moreover, recent studies demonstrated a role
of Tβ4 in inducing the expression of the vascu-
lar endothelial growth factor (VEGF) in colon
cancer cells in experimental models.19 Tβ4 also
partecipates to the modulation of human
colonic immune system23 probably through
degranulation of mucosal mast cells.24
Contrasting results have been published on
the role of Tβ10 in tumour progression. On
one hand, Tβ10 diminishes tumor growth,
angiogenesis and proliferation25 and Tβ10
over-expression has been related to the
increase of apoptosis in human ovarian cancer
cells.25 On the other hand, Tβ10 has been asso-
ciated to the progression of papillary thyroid
carcinoma26 and over-expression of the peptide
has been observed in non-small cell lung can-
cer27 and in pancreatic cancer. 28 The recent
report by our group of a strong expression for
Tβ10 in the human salivary glands during
development,29 induced us to better analyse
the protein expression pattern for Tβ10 in the
oro-gastro-intestinal tract in adult rats, in
order to show if Tβ10 is expressed in the gas-
trointestinal tract in adulthood, and to com-
pare the expression of this peptide with that
reported in the human digestive tract and in
annexed glands.24,30,31 Moreover, rat tissues
were immunostained for Tβ4, with the aim of
verifying the reciprocal interactions of Tβ4
and Tβ10 in the oro-gastrointestinal tract.   
Materials and Methods
In order to test Tβ4 and Tβ10 immunoreac-
tivity in animals, 20 male wistar rats were the
object of our study, divided into 10 male and 10
female. Tissues were obtained from each ani-
mal including samples from tongue, oesopha-
gus, stomach, ileum, colon, parotid gland, sub-
mandibular gland, sublingual gland, liver and
pancreas. All samples were fixed in 10% forma-
lin, paraffin-embedded and routinely processed.
Paraffin sections were immunostained with
anti-Tβ4 and anti-Tβ10 antibodies, using the
labeled streptavidin-biotin complex system
(LSAB2, Dako) in a Dako Autostainer (Dako
Cytomation, Carpinteria, CA, USA). Briefly,
samples were deparaffinized, rehydrated, and
endogenous peroxidase activity was quenced
(30 min) by 0.3% hydrogen peroxide in
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methanol. Slides were then subjected to heat-
induced antigen retrieval by steaming
unstained sections in a Target Retrieval
Solution (Dako TRS pH 6.1) for 30 min. Slides
were then incubated with 10% normal goat
serum in phosphate-buffered saline (PBS) for
60 min to block non-specific binding, followed
by incubation (60 min at room temperature)
with a monoclonal anti-Thymosin Beta 4 anti-
body (Bachem-Peninsula Lab, San Carlos, CA,
USA) and with a monoclonal anti-Thymosin
Beta 10, respectively diluted 1:600 and 1:500 in
the blocking solution. Slides were extensively
washed with PBS containing 0.01% Triton X-
100 and incubated with a secondary reagent
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Table 1. Immunoreactivity for thymosin beta 4 (Tβ4) and thymosin beta 10 (Tβ10) in
rat tissues and humans.      
Organ Tβ4 Rat Tβ10 Rat Tβ4 Human Tβ10 Human
Parothyd - +++ + +
Submandibular gland - +++ + +
Sublingual gland - - + +
Tongue + - + ++
Oesofagus - - + -
Stomach + + + -
Ileum + + + -
Colon + + ++ -
Pancreas +     ++ ++ +
Liver - - +++ +++
Figure 1. Parotid. a) No immunoreactivity for Tβ4 is detected in
the parotid gland; scattered mast cells are strongly immunoreac-
tive for the peptide; OM 250x.  b) A granular and diffuse positiv-
ity for Tβ10 is observed in all the acinar structures; ductal cells
show an apical and homogeneous reactivity for the peptide; OM
400x.
Figure 2. Submandibular glands. a) Tβ4 is not expressed in the
structures of the submandibular glands; only a fine positivity
could be detectable in the surrounding stroma; mast cells show a
strong granular cytoplasmic positivity (yellow arrows); OM 400x.
b) Coarse granules of Tβ10 are observed in the acini of the sub-
mandibular gland (yellow arrows); ductal cells present a fine cyto-
plasmic immunoreactivity for the peptide mainly localized in the
lumen (red arrows); OM 400x.
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(En Vision kit) according with the manufactur-
er instructions (Dako, Glostrup, Denmark).
Diaminobenzidine (DAB) was used as chro-
mogen. After additional washes, colour was
developed using the AEC reagent (Dako), sec-
tions were counterstained with Mayer’s hema-
toxylin and mounted. Sections of reactive
lymph nodes with Tβ4-immunoreactive histio-
cytes were utilized as a positive control. As a
negative control, the same procedure was
applied omitting the primary antibody. 
Results
Parotid
Tβ4 immunoreactivity was completely
absent both in acini and in ducts (Figure 1a).
Tβ10 was expressed both in acinar serous
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Figure 3. Tongue. A weak immunoreactivity for Tβ4 is observed only in the superficial
layers of the tongue’s epithelium; a weak immunostaining for the peptide was observed in
cell membranes of muscle cells (see inset, yellow arrows); OM 250x.
Figure 4. Stomach. a) Immunoreactivity for Tβ4 is expressed in
scattered foveolar cells (see inset, yellow arrows) and in the lumi-
nal surface of the stomach; OM 400x. b) Tβ10 is mainly localized
in the luminal border of the foveolar cells of the stomach; OM
250x.
Figure 5. Ileum. a,b) Tβ4 and Tβ10 are detected in the surface
epithelium of enterocytes covering the villi of the ileum (see
inset, black arrows); OM 400x.
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cells, showing a granular pattern, as well as in
ductal cells, in which a homogeneous cytoplas-
mic staining was detected (Figure 1b).  Submandibular gland
Fine Tβ4-immunoreactive granules were
observed in the periglandular stroma and in
scattered mast cells, in the absence of any
reactivity inside the salivary gland cells
(Figure 2a). A strong reactivity for Tβ10 was
observed in acinar serous cells, appearing as
coarse granules and in mucous cells appearing
as fine granules. The ducts show a homoge-
neous cytoplasmic staining and intraluminal
granular deposits (Figure 2b).  Sublingual glands
No reactivity was detected for Tβ4 and for Tβ10. 
Tongue
A mild immunoreactivity for Tβ4 was detect-
ed in the superficial layers of the stratified
epithelium. Moreover, a weak immunostaining
for the peptide was observed in muscle cells,
mainly localized at the cell membrane (Figure
3). No reactivity for Tβ10 was found.Oesophagus 
Scattered Tβ4-immunoreactive granules
were detected inside the oesophageal lumen.
No reactivity for Tβ10 was observed.Stomach
Immunoreactivity for Tβ4 was restricted to
scattered foveolar cells and to intraluminal
granular deposits (Figure 4a). A similar expres-
sion pattern was observed for Tβ10 (Figure 4b). 
Ileum
Tβ4 was maily expressed in the cytoplasm of
enterocytes covering ileal villi (Figure 5a). A
similar pattern characterized immunoreactivi-
ty for Tβ10 (Figure 5b). Colon
Tβ4 was maily expressed at the apical pole
of enterocytes, and in fine granular deposits
inside the intestinal lumen (Figure 6a), paral-
leling the expression pattern observed for
Tβ10 (Figure 6b).Pancreas
Tβ4 immunoreactivity was restricted to
Langherans islets, in the absence of any sig-
nificant immunostaining in the esocrine pan-
creas (Figure 7a). On the contrary, Tβ10 was
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Figure 6. Colon. a,b) A fine granular positivity for Tβ4 is
observed in the brush border of the enterocytes in the surface
epithelium of the colon and in the intestinal lumen; Tβ10 paral-
lels the immunoreactivity of Tβ4; OM 400x.
Figure 7. Pancreas. a) Tβ4 is diffusely immunoexpressed in the
islets of Langherans; no immunoreactivity is observed in the rest
of pancreatic parenchima; OM 400x. b) Immunoreactivity for
Tβ10 is localized both in islets of Langherans and in the acini
(see inset); the latest show a fine granular positivity in the
absence of ductal reactivity; OM 400x.
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detected both in the exocrine and in the
endocrine pancreas. Endocrine cells of the
Langherans islets showed a strong cytoplasmic
reactivity, whereas in acinar cells Tβ10 was
mainly detected in granular deposits. No
immunostaining was found in ductal cells nor
inside the tubular lumen (Figure 7b).Liver
No reactivity for Tβ4 and Tβ10 was observed
in the liver samples. Data regarding
immunoreactivity for both thymosins in the
different rat organs are summarized in Table 1.
Discussion
The role of Tβ4 and Tβ10, the beta-thy-
mosins expressed virtually in all mammalian
tissues and cells, has not been completely clar-
ified yet. Previous studies on their expression
in the rat central nervous system evidenced
that temporal and cellular patterns of their
expression are different, suggesting that each
beta-thymosin could play a specific physiologi-
cal function during development and in adult-
hood.32 Our study confirms the existence of
marked differences in the distribution of Tβ4
and Tβ10 in the oro-gastro-intestinal tract of
the adult rat. The most striking differences
were found in the parotid and submandibular
glands, in which Tβ4 was absent whereas
immunostaining for Tβ10 was strong and dif-
fuse. On the contrary, no reactivity for both
beta-thymosins was detected in sublingual
glands. These differences in beta-thymosin
expression between different salivary glands
confirm that each beta-thymosin probably
plays a specific role in each salivary gland,
irrespectively of their common embryogenesis.
No significant difference in Tβ4 and Tβ10
expression was present in the gastrointestinal
tract: the absence of reactivity for both beta-
thymosin in the oesofagus contrasts with the
presence of both peptides in the enterocytes of
the remaining gastrointestinal tract, confirm-
ing that a patchy distribution of these peptides
should be expected, even in different parts of
the same system. 
The peculiar pattern for beta thymosins
detected in pancreas deserves some consider-
ations: Tβ10 was strongly expressed both in
the exocrine and in the endocrine cells, where-
as Tβ4 reactivity was restricted to the
Langerhans islet cells. These findings taken
together clearly indicate the presence of a
complex modulation in the expression of beta-
thymosins inside the same organ, each thy-
mosin playing different functions in different
cell types, confirming the β-thymosin enigma.33
When data obtained in rat tissues were com-
pared with immunoreactivity for Tβ4 and Tβ10
in human tissues, significant differences were
evidenced, supporting the hypothesis that
beta-thymosin expression in cells and tissues
is species-specific. The most striking differ-
ences were found in liver specimens, charac-
terized by the complete absence of both thy-
mosins in rat, contrasting with the strong and
diffuse reactivity for Tβ4 and Tβ10 previously
reported in humans.34 However, which is the
role of Tβ4 and Tβ10 in adult rat tissues? The
detailed mechanisms of the action of Tβ4 and
Tβ10 in different mammalian cells and tissues
are not fully understood, as well as the similar-
ities and differences between these isoforms.35
Previous studies evidenced that activities of
these two beta-thymosins are paradoxically
different, Tβ4 promoting cell migration and
angiogenesis, and Tβ10 inhibiting angiogene-
sis.35 Opposing effects on angiogenesis are
likely to be mediated via Tβ4 stimulation and
Tβ10 inhibition of VEGF production.36
Moreover, in contrast to Tβ4, Tβ10 has been
shown to be a negative regulator of tumor
development and progression.37 In short, Tβ4
might promote cell survival by blocking apopto-
sis,38 whereas Tβ10 might exert a proapoptotic
activity, by accelerating apoptotic cell death.39
According with these data, we may speculate
that the complex and pleiotropic  expression of
Tβ4 and Tβ10 here reported in different tis-
sues and cell types might reflect different
direct and indirect effects on the actin
cytoskeleton, as well as modulation of signal-
ing pathways that impact on different cellular
functions. In particular, over-expression of Tβ4
could be related to prevention of apoptosis by
blocking early apoptotic signals,40 whereas
overexpression of Tβ10 might be related to its
pro-apoptotic activity and to a down-regulation
of cell growth35 and of angiogenesis.36
Finally, this study, one of the few in which
the immunohistochemical expression pattern
of Tβ4 and Tβ10 has been paralleled in the
same tissues, evidenced that detailed mecha-
nisms of the action of beta-thymosins in differ-
ent cells and tissues are not fully understood,
and show that our lack of knowledge is partic-
ularly evident regarding mature adult tissues,
the vast majority of studies on the role of beta-
thymosins having been carried out in fetal or
tumoral tissues. Further studies exploring the
molecular events that are associated with Tβ4
and Tβ10 overexpression or down-regulation
are required, in order to give a solution to the
thymosin enigma.     
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